|
GOLGA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.45720016450935E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.31019997471083E-09 |
| Normal-vs-Stage2 |
1.264380E-03 |
| Normal-vs-Stage3 |
1.98799998685217E-09 |
| Normal-vs-Stage4 |
5.19459997239125E-09 |
| Stage1-vs-Stage2 |
1.357180E-01 |
| Stage1-vs-Stage3 |
3.487000E-01 |
| Stage1-vs-Stage4 |
1.331210E-01 |
| Stage2-vs-Stage3 |
4.400100E-02 |
| Stage2-vs-Stage4 |
1.734190E-02 |
| Stage3-vs-Stage4 |
4.513600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.90647539158817E-12 |
| Normal-vs-AfricanAmerican |
2.426400E-02 |
| Normal-vs-Asian |
1.45260000028458E-07 |
| Caucasian-vs-AfricanAmerican |
1.323980E-01 |
| Caucasian-vs-Asian |
6.657400E-01 |
| AfricanAmerican-vs-Asian |
2.120200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.9703999966132E-08 |
| Normal-vs-Female |
8.31300028814042E-10 |
| Male-vs-Female |
9.949600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.78139999920768E-08 |
| Normal-vs-Age(41-60Yrs) |
4.27269997160806E-09 |
| Normal-vs-Age(61-80Yrs) |
1.84190000029893E-07 |
| Normal-vs-Age(81-100Yrs) |
5.483200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.739400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.933200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.798800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.374400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.672200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.074200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.149950E-01 |
| Classical-VS-Follicular |
3.194600E-01 |
| Classical-VS-Other |
3.460200E-01 |
| Classical-VS-Normal |
7.7413997434661E-10 |
| Tall-VS-Follicular |
3.235900E-02 |
| Tall-VS-Other |
8.813400E-01 |
| Tall-VS-Normal |
1.52799999986186E-07 |
| Follicular-VS-Other |
1.058210E-01 |
| Follicular-VS-Normal |
2.602000E-04 |
| Other-VS-Normal |
1.956570E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.97630000037452E-08 |
| Normal-vs-N1 |
1.59099999841317E-09 |
| N0-vs-N1 |
1.702570E-01 |
|
|
